IL33 and viral infectious disease: In the context of viral infection, it is generally accepted that full-length IL-33 is released as a bioactive form by cells that undergo necrosis and necroptosis [148,149] (Figure 3B), as well as by cells that undergo cytolysis or release their nuclear contents [150].